Skandinaviska Enskilda Banken (SEB)
ROIV icon

Skandinaviska Enskilda Banken (SEB)’s Roivant Sciences ROIV Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-74,489
Closed -$839K – 869
2025
Q2 		$839K Hold
74,489
– – ﹤0.01% 663
2025
Q1 		$751K Sell
74,489
-40,987
-35% -$443K ﹤0.01% 666
2024
Q4 		$1.32M Sell
115,476
-83,811
-42% -$991K 0.01% 627
2024
Q3 		$2.3M Hold
199,287
– – 0.01% 560
2024
Q2 		$2.11M Sell
199,287
-563,249
-74% -$6.17M 0.01% 553
2024
Q1 		$8.05M Sell
762,536
-174,438
-19% -$1.88M 0.04% 323
2023
Q4 		$10.5M Hold
936,974
– – 0.06% 251
2023
Q3 		$11M Buy
936,974
+806,767
+620% +$9.12M 0.07% 232
2023
Q2 		$1.31M Buy
+130,207
New +$1.16M 0.01% 652

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ROIV Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 74,489 shares — an estimated $839K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ROIV in Q2 2023 and held it in 9 quarters. The position peaked at $11M in Q3 2023. 338 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 74,489 Roivant Sciences shares in Q3 2025, an estimated $839K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Roivant Sciences in Q2 2023 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Roivant Sciences position peaked at $11M in Q3 2023.
  • 338 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.